Immunity against Neisseria meningitidis Serogroup C in the Dutch Population before and after Introduction of the Meningococcal C Conjugate Vaccine

BACKGROUND: In 2002 a Meningococcal serogroup C (MenC) conjugate vaccine, with tetanus toxoid as carrier protein, was introduced in the Netherlands as a single-dose at 14 months of age. A catch-up campaign was performed targeting all individuals aged 14 months to 18 years. We determined the MenC-spe...

Descripción completa

Detalles Bibliográficos
Autores principales: de Voer, Richarda M., Mollema, Liesbeth, Schepp, Rutger M., de Greeff, Sabine C., van Gageldonk, Pieter G. M., de Melker, Hester E., Sanders, Elisabeth A. M., Berbers, Guy A. M., van der Klis, Fiona R. M.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921331/
https://www.ncbi.nlm.nih.gov/pubmed/20730091
http://dx.doi.org/10.1371/journal.pone.0012144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921331/
https://www.ncbi.nlm.nih.gov/pubmed/20730091
http://dx.doi.org/10.1371/journal.pone.0012144

Ejemplares similares